{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-070826","form_type":"8-K","ticker":"HIND","cik":"0001427570","company_name":"Vyome Holdings, Inc","filed_at":"2025-07-25T23:59:59+00:00","discovered_at":"2026-05-14T18:02:43.966699+00:00","generated_at":"2026-05-18T01:06:41.979389+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"ReShape Lifesciences shareholders approve reverse split, stock issuance; asset sale vote postponed to Aug 7","bullets":["Proposals 1,4,5,6 approved; meetings on asset sale (Prop 2) and merger charter (Prop 3) adjourned to Aug 7.","Prop 1 (shares for merger) passed: 583,748 for, 59,520 against, 235,196 abstain, 604,121 broker non-votes.","Prop 4 (reverse stock split 1:2 to 1:5) approved: 1,249,487 for, 227,492 against, 5,606 abstain.","Reconvened meeting Aug 7 at 11:30am ET virtual; record date remains June 9, 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-070826","json":"https://secwatch.observer/filing/0001104659-25-070826.json","markdown":"https://secwatch.observer/filing/0001104659-25-070826.md","text":"https://secwatch.observer/filing/0001104659-25-070826.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1427570/000110465925070826/0001104659-25-070826-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1427570/000110465925070826/tm2521354d4_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T01:06:41.979389+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}